- Home
- BFRI vs JAGX Comparison
BFRI vs JAGX Comparison
Compare BFRI & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRI
- JAGX
- Stock Information
- Founded
- BFRI 1997
- JAGX 2013
- Country
- BFRI United States
- JAGX United States
- Employees
- BFRI N/A
- JAGX N/A
- Industry
- BFRI Biotechnology: Pharmaceutical Preparations
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- BFRI Health Care
- JAGX Health Care
- Exchange
- BFRI Nasdaq
- JAGX Nasdaq
- Market Cap
- BFRI 7.5M
- JAGX 7.4M
- IPO Year
- BFRI 2021
- JAGX N/A
- Fundamental
- Price
- BFRI $0.56
- JAGX $4.40
- Analyst Decision
- BFRI Strong Buy
- JAGX Strong Buy
- Analyst Count
- BFRI 1
- JAGX 1
- Target Price
- BFRI $2.75
- JAGX $60.00
- AVG Volume (30 Days)
- BFRI 174.6K
- JAGX 109.9K
- Earning Date
- BFRI 05-15-2025
- JAGX 05-15-2025
- Dividend Yield
- BFRI N/A
- JAGX N/A
- EPS Growth
- BFRI N/A
- JAGX N/A
- EPS
- BFRI N/A
- JAGX N/A
- Revenue
- BFRI $37,997,000.00
- JAGX $11,552,000.00
- Revenue This Year
- BFRI $18.57
- JAGX $22.41
- Revenue Next Year
- BFRI $20.17
- JAGX $30.00
- P/E Ratio
- BFRI N/A
- JAGX N/A
- Revenue Growth
- BFRI 14.28
- JAGX 13.93
- 52 Week Low
- BFRI $0.54
- JAGX $4.02
- 52 Week High
- BFRI $2.22
- JAGX $130.25
- Technical
- Relative Strength Index (RSI)
- BFRI 29.93
- JAGX 33.49
- Support Level
- BFRI $0.58
- JAGX $4.27
- Resistance Level
- BFRI $0.68
- JAGX $4.90
- Average True Range (ATR)
- BFRI 0.06
- JAGX 0.79
- MACD
- BFRI -0.01
- JAGX -0.24
- Stochastic Oscillator
- BFRI 11.21
- JAGX 6.01
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.